抗抑郁药治疗在瘤学患者中的实际使用,有效性和耐受性
Alessio Simonetti1,2, Flavia Grisoni3, Antonio Restaino3
1Department of Neurosciences, Head-Neck and Chest, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Psycho-oncology
|November 30, 2025
概括
抗抑郁药有效地治疗癌症患者的抑郁症,而西显示出更好的耐受性. 这凸显了在瘤学药物治疗中考虑副作用和药物相互作用的重要性.
科学领域:
- 在瘤学瘤学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抑郁症显著影响癌症患者的预后和生活质量.
- 关于抗抑郁药在癌症患者中的有效性和耐受性,现实世界数据有限.
研究的目的:
- 评估抗抑郁药在患有重大抑郁症 (MDD) 的瘤病患者的有效性和耐受性.
- 为了调查这一群体中抗抑郁药物处方趋势.
主要方法:
- 一项为期6个月的追溯观察性研究,对170名患有MDD的瘤门诊患者进行了研究.
- 患者接受了TCA,SSRI,SNRIs或子素的单疗法.
- 症状评估包括在基线和6个月的抑郁,焦虑,自杀倾向和兴奋等级.
主要成果:
- 所有抗抑郁药类药物在减少抑郁,焦虑和自杀念头方面都表现出相似的有效性.
- 沃尔提奥塞丁表现出良好的耐受性概况,没有报告的不良反应.
- 由于副作用,SSRI和SNRIs的脱学率较高;SSRI被处方最多,其次是多式联络药物.
结论:
- 抗抑郁药对癌症患者的抑郁症同样有效.
- 伏尔托克塞丁是一种耐受性良好的选择,特别是对于化疗患者.
- 耐受性和药物相互作用概况在瘤学抗抑郁药物选择中至关重要.
更多相关视频
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
761
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
761
Antidepressant Drugs: Overview
1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Therapeutic Drug Monitoring: Affecting Factors
163
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
163
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K
Cancer Survival Analysis
624
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
624


